Bashkim Kadriu Selected Research

imidazenil

12/2011	Absence of tolerance to the anticonvulsant and neuroprotective effects of imidazenil against DFP-induced seizure and neuronal damage.
3/2011	Acute imidazenil treatment after the onset of DFP-induced seizure is more effective and longer lasting than midazolam at preventing seizure activity and brain neuropathology.
2/2009	Imidazenil, a non-sedating anticonvulsant benzodiazepine, is more potent than diazepam in protecting against DFP-induced seizures and neuronal damage.
9/2008	The combination of huperzine A and imidazenil is an effective strategy to prevent diisopropyl fluorophosphate toxicity in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bashkim Kadriu Research Topics

Disease

12	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 03/2017
10	Bipolar Disorder (Manic Depressive Psychosis) 01/2024 - 03/2007
9	Treatment-Resistant Depressive Disorder 12/2023 - 01/2019
4	Seizures (Absence Seizure) 12/2011 - 09/2008
4	Amnesia (Dissociative Amnesia) 12/2011 - 09/2008
2	Anhedonia 01/2024 - 01/2018
2	Psychotic Disorders (Schizoaffective Disorder) 05/2013 - 03/2007
2	Schizophrenia (Dementia Praecox) 06/2010 - 03/2007
1	Feeding and Eating Disorders (Eating Disorder) 01/2024
1	Mental Disorders (Mental Disorder) 01/2024
1	Pain (Aches) 01/2024
1	Substance-Related Disorders (Drug Abuse) 01/2024
1	Anxiety Disorders (Anxiety Disorder) 01/2024
1	Chronic Pain 12/2023
1	Inflammation (Inflammations) 01/2023
1	Weight Gain 01/2023
1	Neuralgia (Stump Neuralgia) 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022
1	Complex Regional Pain Syndromes 01/2022
1	Fatigue 01/2019
1	Genetic Risk Score 12/2018
1	Insulin Resistance 06/2018
1	Tonic-Clonic Epilepsy (Epilepsy, Tonic Clonic) 06/2010
1	Respiratory Insufficiency (Respiratory Failure) 02/2009
1	Poisoning 02/2009
1	Status Epilepticus (Complex Partial Status Epilepticus) 02/2009

Drug/Important Bio-Agent (IBA)

18	Ketamine FDA LinkGeneric 01/2024 - 03/2017
11	Antidepressive Agents (Antidepressants)IBA 01/2024 - 06/2018
4	EsketamineIBA 01/2024 - 10/2018
4	Isoflurophate (DFP)FDA Link 12/2011 - 09/2008
4	Diazepam (Valium)FDA LinkGeneric 12/2011 - 09/2008
4	imidazenilIBA 12/2011 - 09/2008
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2018
3	OrganophosphatesIBA 12/2011 - 02/2009
3	fluorophosphate (sodium monofluorophosphate)FDA Link 12/2011 - 02/2009
3	Nerve AgentsIBA 12/2011 - 02/2009
3	Anticonvulsants (Antiepileptic Drugs)IBA 12/2011 - 02/2009
3	gamma-Aminobutyric Acid (GABA)IBA 03/2011 - 09/2008
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020 - 01/2019
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2020 - 01/2019
2	LigandsIBA 01/2019 - 02/2009
2	MethyltransferasesIBA 05/2013 - 03/2007
2	DNA (Deoxyribonucleic Acid)IBA 05/2013 - 03/2007
2	BenzodiazepinesIBA 03/2011 - 02/2009
2	GABA-A Receptors (GABA(A) Receptor)IBA 03/2011 - 09/2008
1	KynurenineIBA 01/2021
1	ProdrugsIBA 01/2020
1	4-chlorokynurenineIBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2019
1	Genetic Markers (Genetic Marker)IBA 12/2018
1	Scopolamine (Hyoscine)FDA Link 12/2018
1	KATP ChannelsIBA 06/2018
1	Potassium Channels (Potassium Channel)IBA 06/2018
1	Diazoxide (Hyperstat)FDA Link 06/2018
1	Protons (Proton)IBA 06/2018
1	SolutionsIBA 01/2018
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 05/2013
1	Midazolam (Versed)FDA LinkGeneric 12/2011
1	Methionine (L-Methionine)FDA Link 06/2010
1	Valproic Acid (Depakote)FDA LinkGeneric 06/2010
1	imidazole mustard (BIC)IBA 06/2010
1	BicucullineIBA 02/2009
1	Atropine FDA LinkGeneric 02/2009
1	huperzine AIBA 09/2008
1	CarbonIBA 03/2007
1	CytosineIBA 03/2007
1	EnzymesIBA 03/2007

Therapy/Procedure

2	Therapeutics 01/2024 - 01/2020
2	Intravenous Infusions 01/2019 - 01/2019